Choosing a CBD oil comes down to three things you can actually verify before buying: whether the label tells the truth about what is inside, whether the product has been tested for contaminants, and whether the formulation suits your needs. The trouble is that roughly half of CBD products on the market contain a meaningfully different amount of CBD than what their labels claim, and the regulatory landscape in most countries does little to stop that. Understanding a few key markers of quality can help you avoid wasting money on a dud bottle or, worse, exposing yourself to something harmful.
The Label Accuracy Problem
If you grab a bottle of CBD oil off a shelf or order one online, the number printed on the label might be wrong. A 2022 study tested 80 commercially available CBD products using laboratory analysis and found that only about 54% of them fell within 10% of the CBD concentration stated on the label. Of the products that missed that mark, roughly a third contained less CBD than advertised, while the rest contained more. The gap between what the label said and what was actually in the bottle ranged up to about 30 mg/mL off.1PubMed Central. Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim Getting less than you paid for is frustrating; getting substantially more can be a safety issue if you are trying to stay at a specific dose, especially alongside other medications.
This is not a fringe problem limited to gas-station brands. The products in that study were purchased from mainstream retail channels. The pattern shows up consistently across research going back years, and it persists because CBD products in most markets are not regulated the way pharmaceuticals or even most dietary supplements are. There is no pre-market approval step requiring a manufacturer to prove the label is accurate before selling the product. That puts the burden on you to do some digging.
What a Certificate of Analysis Should Tell You
The single most useful document you can request or look up is the product’s certificate of analysis, usually abbreviated as COA. A COA is a report from an independent laboratory that tests a sample of the product for its cannabinoid content and, ideally, for contaminants. Reputable brands make these available on their websites, often searchable by batch number. If a company does not publish COAs at all, treat that as a red flag large enough to walk away from the purchase.
A good COA should include several things. First, look for the cannabinoid profile. This confirms how much CBD is actually present, and it also shows whether THC is in the product and at what concentration. Accredited labs typically use high-performance liquid chromatography (HPLC) to separate and measure each cannabinoid, and the COA should note the lab’s accreditation, often under a standard called ISO/IEC 17025.2PubMed Central. Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements Second, look for contaminant panels: heavy metals, pesticide residues, and microbial contamination. If the COA only shows cannabinoid content and nothing else, the testing was incomplete. Third, check that the batch number on the COA matches the batch number on your bottle. A COA from a different production run is not evidence about what is in your hands.
Heavy Metals and Why Hemp Is Especially Prone to Them
Hemp is a bioaccumulator, meaning it pulls elements out of the soil and stores them in its tissues with unusual efficiency. This is actually one of the reasons the plant has been studied for cleaning up contaminated land. Its deep root system and tolerance for heavy metals make it a candidate for what researchers call phytoremediation.3PubMed Central. Potential of Industrial Hemp for Phytoremediation of Heavy Metals That is great for environmental cleanup. It is less great when the same plant is being grown to produce something you plan to put in your body.
The list of elements hemp can absorb from soil includes lead, cadmium, mercury, arsenic, nickel, chromium, and others. A comprehensive review noted a significant gap in understanding just how much of these elements hemp accumulates under normal agricultural conditions, and flagged the potential health risks for consumers.4PubMed. The comprehensive review about elements accumulation in industrial hemp (Cannabis sativa L.) While roots tend to trap the highest concentrations of heavy metals, research has shown that even the flowers, the part of the plant used to make CBD oil, can exceed the World Health Organization’s thresholds for cadmium and nickel at relatively modest soil contamination levels.5PubMed Central. Heavy metals in cannabis: plant contamination and effects on cannabinoid production
What this means practically: the quality of the soil the hemp was grown in matters. Organic certification is a partial signal, but what you really want to see is a COA showing that heavy-metal testing was performed and the results fell below established safety limits. Products sourced from hemp grown on former industrial land or in regions without soil-quality standards carry more risk.
Pesticide Residues and Microbial Contaminants
Pesticide contamination is common in cannabis flower. An analysis of Italian-grown hemp inflorescences found that 87% of samples contained fungicides and insecticides, with concentrations ranging widely.6PubMed. Toxicological aspects of cannabinoid, pesticide and metal levels detected in light Cannabis inflorescences grown in Italy The extraction process that turns hemp flower into CBD oil does not necessarily remove these residues. Research on separation methods has shown that while some pesticides are easily separated from CBD during extraction, others co-elute with it, meaning they stick to the CBD fraction and end up in the final product.7Industrial Crops and Products. Approach for simultaneous cannabidiol isolation and pesticide removal from hemp extracts with liquid-liquid chromatography States like Oregon have regulated lists of pesticides that must be tested for in cannabis products, but in many jurisdictions, no such requirement exists.
Microbial contaminants are another concern that often flies under the radar. The fungal ecosystem living on cannabis and hemp flowers includes over 100 species, some of which produce mycotoxins that can be harmful to humans. Genera like Aspergillus and Fusarium are particularly worrying because they can trigger infections in people with weakened immune systems and produce toxins that are problematic for everyone.8PubMed Central. Fungal and mycotoxin contaminants in cannabis and hemp flowers: implications for consumer health and directions for further research A thorough COA will include microbial testing. If it does not, and especially if you are immunocompromised, that missing panel matters.
Extraction Methods and What They Mean for Purity
Most CBD oil starts with an extraction step that pulls cannabinoids and other compounds out of the hemp plant. The two most common commercial methods are CO₂ extraction and solvent-based extraction using ethanol or hydrocarbons. Supercritical CO₂ extraction has become something of an industry standard among higher-end brands. Research comparing it to solvent extraction found that CO₂ produced a more selective extraction, yielding an oil enriched to about 50% CBD by weight while avoiding toxic organic solvents entirely.9Industrial Crops and Products. Cannabidiol from inflorescences of Cannabis sativa L.: Green extraction and purification processes
Solvent-based extraction is not inherently dangerous, but it introduces the question of residual solvents in the finished product. Reputable manufacturers will test for these and list the results on the COA. CO₂ extraction avoids this issue by design, since the carbon dioxide used as the solvent simply evaporates at normal pressure. Neither method is a guarantee of a clean final product on its own, however. The extraction only concentrates whatever is in the plant material, contaminants included. That is why starting material quality and post-extraction testing both matter more than the extraction method alone.
Full-Spectrum, Broad-Spectrum, and Isolate
CBD products are typically sold under one of three labels describing their cannabinoid makeup. Isolate is pure CBD with no other cannabinoids or plant compounds. Broad-spectrum products contain CBD alongside other cannabinoids and terpenes but with THC removed. Full-spectrum products keep everything, including trace amounts of THC, usually under 0.3% by weight to comply with legal thresholds in the United States.
The distinction matters because there is evidence that THC, even at low concentrations, affects how your body absorbs CBD. A pharmacokinetic comparison found that the presence of just 0.2% THC increased the oral bioavailability of CBD in animal models, suggesting that full-spectrum products may deliver more CBD into your bloodstream per milligram than isolates do.10PubMed. Comparative Pharmacokinetics of Commercially Available Cannabidiol Isolate, Broad-Spectrum, and Full-Spectrum Products Researchers have also pointed out that studies using purified CBD alone may miss the biological benefits that come from the full range of compounds in the plant, including terpenes, which have their own anti-inflammatory and analgesic properties. There is reason to believe that the whole extract does more than the sum of its isolated parts, though the specific mechanisms are still being worked out.
That said, full-spectrum products are not right for everyone. Even trace amounts of THC can show up on a drug test, which matters if your employment depends on passing one. For people who are sensitive to THC’s psychoactive effects or who live in jurisdictions with zero-tolerance THC policies, broad-spectrum or isolate products are the safer choice. Pick the spectrum based on your situation, not based on marketing claims about one type being universally superior.
Formulation, Carrier Oils, and the Sublingual Myth
CBD is poorly soluble in water and gets heavily broken down by the liver on its first pass through, which means a large portion of what you swallow never makes it into your bloodstream. Carrier oils help, but the type of oil matters. A study comparing CBD emulsions made with different carrier oils found that long-chain triglycerides, the kind found in oils like olive oil and sesame oil, produced higher bioavailability (about 43%) than medium-chain triglycerides (about 33%), the type found in MCT oil derived from coconut.11PubMed. Digestion behavior, in vitro and in vivo bioavailability of cannabidiol in emulsions stabilized by whey protein-maltodextrin conjugate: Impact of carrier oil MCT oil is widely used in CBD products partly because of its neutral flavor and partly because of marketing around medium-chain fats, but the absorption data suggest it is not necessarily the best vehicle.
There is also a persistent belief that holding CBD oil under your tongue (sublingual administration) allows it to absorb directly through the oral membranes, bypassing the liver and getting into your system faster. The concept is sound in theory, and oral mucosal delivery is a legitimate pharmaceutical strategy for some drugs.12PubMed. Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and Permeation Enhancement In practice, however, a head-to-head trial comparing CBD oil drops held sublingually versus CBD swallowed in gelatin capsules found that the blood-level profiles were essentially identical. The researchers concluded that people likely swallow the oil before meaningful absorption through the mouth lining occurs.13PubMed. Cannabidiol Oil Ingested as Sublingual Drops or Within Gelatin Capsules Shows Similar Pharmacokinetic Profiles in Healthy Males This does not mean sublingual products are bad, but it does mean you probably should not pay a premium for a sublingual delivery format expecting a meaningfully different absorption profile compared to just swallowing the same oil.
Dosing Is Still a Guessing Game
One of the most frustrating aspects of choosing a CBD product is that there is no broadly agreed-upon dose for most of the conditions people use it for. A systematic review of clinical trials found that studies reporting positive results used doses ranging from less than 1 mg per kilogram of body weight per day up to 50 mg/kg/day, a span so wide it is practically useless as guidance.14PubMed Central. A systematic review of cannabidiol dosing in clinical populations Another review highlighted that the doses, dosing schedules, and formulations used across human trials were so varied that pooling them for a meaningful analysis was not feasible. Despite the existence of online “dose calculators,” the scientific basis for the numbers they spit out is unclear.15PubMed Central. Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials
What the research does make fairly clear is that higher potency products are not automatically better. The FDA-approved CBD medication used for severe epilepsy is dosed at levels that dwarf what most consumer products contain, and that dosing comes with close medical supervision for good reason. For general wellness use, starting low and adjusting gradually is the most common practical advice, but “low” and “gradually” are left largely undefined by the evidence. A product’s potency, measured in milligrams of CBD per milliliter or per serving, determines how easy it is to control your intake. Higher-concentration oils let you take smaller volumes for the same dose, which can be convenient, but they also make it easier to accidentally take more than you intended.
Drug Interactions and Liver Safety
CBD is processed in the liver by the same family of enzymes that metabolize a huge number of prescription drugs. When CBD competes for those enzymes, it can raise or lower the blood levels of other medications you are taking. A comprehensive review found that CBD interacts with anti-epileptic drugs, antidepressants, opioid painkillers, and even common over-the-counter drugs like acetaminophen.16PubMed Central. Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review A systematic review of drug interactions reinforced that the enzymes involved, primarily CYP3A4, CYP2C9, and CYP2C19, are the same ones responsible for metabolizing most prescription medications, creating a broad potential for interactions, especially with drugs that have a narrow margin between a therapeutic and a toxic dose.17PubMed Central. Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis
The liver itself can also be affected. A review of CBD-associated liver injury found that the vast majority of cases involving elevated liver enzymes or outright liver damage occurred in people taking more than 1,000 mg of CBD per day. However, there were outlier cases at moderate doses in the 300 to 999 mg range, even in otherwise healthy adults.18PubMed Central. Clinical guidance for cannabidiol‐associated hepatotoxicity: A narrative review These doses are well above what most consumer CBD products provide per serving, but people who stack multiple products or take high-potency formulations can reach them. If you take prescription medications or have any history of liver problems, talking to a doctor before adding CBD is not a formality. It is genuinely important.
Health Claims and Regulatory Gaps
The CBD market exists in a regulatory gray zone in much of the world. In the United States, the FDA has approved exactly one CBD-based medication for specific seizure disorders. Everything else, every tincture, gummy, and topical cream sold for pain, anxiety, sleep, or general wellness, is sold without FDA approval and is not legally permitted to make therapeutic claims. A retrospective analysis of FDA warning letters found that 97% of the letters sent to CBD companies cited violations for marketing CBD as an unapproved drug. The therapeutic claims made in those cases spanned more than 125 health conditions, including cancer, diabetes, and arthritis.19PubMed Central. Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019
This pattern accelerated during the pandemic, when CBD products were among the most frequent subjects of FDA violation letters for promoting unapproved products with unsubstantiated health claims.20PubMed Central. Unsubstantiated health claims for COVID-19 infections are led by cannabidiol: return of snake oil medicine The practical takeaway: be deeply skeptical of any brand making specific health claims on its packaging or website. Companies that market CBD as a cure or treatment for named diseases are either ignorant of the regulations or deliberately violating them, and neither inspires confidence in their product quality.
Some states have implemented their own quality standards for cannabis and CBD products sold within their borders, including requirements for testing, labeling, and manufacturing practices that parallel pharmaceutical-grade controls.21PubMed Central. Quality Standards in State Programs Permitting Cannabis for Medical Uses Products sold through state-regulated medical cannabis programs tend to be held to higher standards than those sold as general wellness products through unregulated channels. If you have access to a regulated dispensary, that is generally a safer bet than ordering from an unknown online retailer.
Adulteration and Synthetic Cannabinoids
A more insidious risk in the CBD market involves products that contain cannabinoids not derived from the plant at all. Delta-8-THC, a mildly psychoactive cannabinoid that occurs naturally in cannabis in tiny amounts, has become widely available as a synthetic product manufactured by chemically converting CBD. Because it is synthesized rather than extracted, delta-8-THC products are expected to contain impurities from residual chemicals and reaction byproducts.22PubMed Central. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol Some CBD products have been found to contain delta-8-THC or other synthetic cannabinoids without disclosing them on the label, which raises both safety and legal concerns.
A COA from a third-party lab is again your best defense. Products that have been tested for a full panel of cannabinoids will show if anything unexpected is present. If a product’s COA only tests for CBD and THC without screening for other cannabinoids, it may miss these adulterants.
Storage and Shelf Life
CBD is not indefinitely stable. Heat, light, and oxygen all degrade it over time. Research on thermal degradation has shown that sustained exposure to heat breaks CBD down, producing trace amounts of THC and other breakdown products like cannabinol (CBN) in the process.23PubMed Central. Effect of temperature in the degradation of cannabinoids: From a brief residence in the gas chromatography inlet port to a longer period in thermal treatments This degradation is slow at room temperature but accelerates with heat. Storing CBD oil in a cool, dark place with the cap tightly sealed is the simplest way to preserve its potency. Leaving a bottle in a hot car or on a sunny windowsill for weeks will measurably reduce what you are actually getting per dose.
Most manufacturers print an expiration date, typically one to two years from production. If your oil has changed color significantly, developed an off smell, or tastes noticeably different than when you first opened it, the cannabinoid profile has likely shifted.
Cannabis-Related Allergies
A concern that rarely makes it into CBD buying guides is allergic reactions. Cannabis can trigger both immediate hypersensitivity reactions and delayed-type allergic responses. Recognized allergens in the plant include proteins related to those found in common plant-based food allergens, which means people with existing pollen or fruit allergies may be at higher risk of cross-reactivity. If you experience hives, itching, swelling, or respiratory symptoms after using a CBD product, an allergic reaction to plant-derived components is a real possibility worth raising with an allergist rather than dismissing as a one-off sensitivity.